Hypertensive disorders during pregnancy - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Hypertensive disorders during pregnancy

Description:

No proteinuria BP returns to normal within 12 weeks postpartum Final diagnosis is only made postpartum Chronic hypertension Hypertension before pregnancy or ... – PowerPoint PPT presentation

Number of Views:1491
Avg rating:3.0/5.0
Slides: 20
Provided by: Dr243
Category:

less

Transcript and Presenter's Notes

Title: Hypertensive disorders during pregnancy


1
(No Transcript)
2
Hypertensive disorders during pregnancy
  • ?. ???? ???? ??????
  • ??????? ???? ???? ?? ???? ???????
  • ???? ???? / ?????
    ??????
  • 9/10/2011

3
Definition and Classification
4
HYPERTENSION
  • Definition Hypertension is two or more blood
    pressure readings of 140/90 mmHg at least 6
    hours apart in sitting position.

5
Gestational hypertension
  • BP reading 140/90 mmHg for the first time
    during pregnancy.
  • No proteinuria
  • BP returns to normal within 12 weeks postpartum
  • Final diagnosis is only made postpartum

6
Chronic hypertension
  • Hypertension before pregnancy or diagnosed before
    20 weeks gestation
  • Hypertension first diagnosed after 20 weeks
    gestation and persisting after 12 weeks
    postpartum

7
Pre-Eclampsia
  • BP 140/90 mmHg or more after 20 weeks gestation
  • Proteinuria 1 by urine dipstick or a total
    protein level 300 mg or more per 24 hour

8
Eclampsia
  • Central nervous system involvement with the
    occurrence of convulsions that cannot be
    attributed to other causes

9
Predisposing factors
  • Age
  • Obesity
  • Parity
  • Socioeconomic status
  • Genetic predisposition
  • Obstetric complication
  • Existing medical condition e.g. diabetes renal
    disease

10
Pathophysiological changes in pre-eclampsia
  • Capillary leak causing edema, proteinuria and
    hemoconcentration
  • Vasospasm causing hypertension, oliguria, organ
    ischemia, abruptio placentae and occurrence of
    convulsion
  • Activation of coagulation causing
    thrombocytopenia the release of cytokines
    peroxidases causing more reduction in
    uteroplacental perfusion
  • Release of vasoactive agents (PG, NO, Endothelin)
    causing reduced uteroplacental perfusion

11
Pathology
  • Hemorrhage and necrosis in many organs, secondary
    to arteriolar constriction
  • Glomerular capillary endotheliosis

12
Investigations
  • Hematologic increased hematocrit level
    thrombocytopenia
  • Hepatic impairment elevated liver enzymes
  • Cardiopulmonary impairment left ventricular
    failure and pulmonary edema
  • Fetal impairment IUGR, oligohydramnios,
    iatrogenic premature delivery and abruptio
    placenta , increased prenatal morbidity
    mortality

13
MANAGEMENT
  • Early detection appropriate management are
    essential to improve maternal fetal outcome
  • Timing of delivery in mild pre-elampsia
  • gestation gt 38 weeks, termination of pregnancy
    yields better fetal maternal outcome
  • 34-38 weeks expectant management
  • Gestationlt 34 weeks expectant manegment
    admistration of glucocorticoid to accelerate
    fetal lung maturation.

14
Expectant management of pre-eclampsia
  • Hospital addmition
  • Bed rest
  • Frequent BP measurement
  • Laboratory investigations.
  • Fetal evaluation by ultrasound
  • Avoid giving antihypertensive diuretics
  • Delivery if fetus reaches term or when any sign
    of maternal or fetal instability occures

15
Convulsion prophylaxis
  • Intravenous magnesium sulphate to arrest and/or
    prevent convulsion. Loading dose is 6 gm diluted
    in 200 ml Ringer lactate over 20 min. Maintenance
    dose 2 gm /hour starting immediately after
    loading dose continue for 24 hour after
    delivery or after the last convulsion.
  • Calsium gluconate 1gm i.v pushed over a few
    minutes may be administered to reverse magnesium
    sulphate toxicity

16
Antihypertensive therapy
  • Anti-hypertensive therapy protect against
    occurrence of maternal intracranial hemorrhage
  • Chronic therapy of moderate hypertension does not
    delay progression of the disease, prolong
    gestation, or reduce the risk of seizures
  • The maternal BP should not reduced below 140/90
    mmHg because lower pressures may decrease
    utero-placental perfusion
  • The most commonly used agents during pregnancy
    are Nifedipine, Labetalol, Hydralazine sodium
    nitroprusside

17
Termination of pregnancy
  • Mode of delivery
  • If the women is not in labor, examine the cervix,
    if the cervix is fit for induction, start
    induction of labor
  • If the patient is in labor there is adequate
    progress as seen on the partograph with no fetal
    or maternal complications, continue vaginal
    delivery
  • If there is an obstetric indication for CS
    delivery perform the procedure

18
Reference
  • Dienstage JL, Isselbacher .Women's
    disorders.InFauci AS et al., eds .Harrison
    principles of internal medicine, 17 th ed.New
    York,McGraw-Hill, 2008413-416.

19
THANKS
Write a Comment
User Comments (0)
About PowerShow.com